902 related articles for article (PubMed ID: 17550131)
1. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
Martínez-Sánchez G; Giuliani A
J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
[TBL] [Abstract][Full Text] [Related]
2. Natural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1).
Nagle DG; Zhou YD
Curr Drug Targets; 2006 Mar; 7(3):355-69. PubMed ID: 16515532
[TBL] [Abstract][Full Text] [Related]
3. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
Patiar S; Harris AL
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
[TBL] [Abstract][Full Text] [Related]
4. Natural compounds and the hypoxia-inducible factor (HIF) signalling pathway.
Manolescu B; Oprea E; Busu C; Cercasov C
Biochimie; 2009; 91(11-12):1347-58. PubMed ID: 19703512
[TBL] [Abstract][Full Text] [Related]
5. Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
Poon E; Harris AL; Ashcroft M
Expert Rev Mol Med; 2009 Aug; 11():e26. PubMed ID: 19709449
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells.
Jung SN; Yang WK; Kim J; Kim HS; Kim EJ; Yun H; Park H; Kim SS; Choe W; Kang I; Ha J
Carcinogenesis; 2008 Apr; 29(4):713-21. PubMed ID: 18258605
[TBL] [Abstract][Full Text] [Related]
7. The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison.
Görlach A; Bonello S
Biochem J; 2008 Jun; 412(3):e17-9. PubMed ID: 18498249
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
Xia Y; Choi HK; Lee K
Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition.
Choi H; Chun YS; Kim SW; Kim MS; Park JW
Mol Pharmacol; 2006 Nov; 70(5):1664-71. PubMed ID: 16880289
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species and HIF-1 signalling in cancer.
Galanis A; Pappa A; Giannakakis A; Lanitis E; Dangaj D; Sandaltzopoulos R
Cancer Lett; 2008 Jul; 266(1):12-20. PubMed ID: 18378391
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
Hewitson KS; Schofield CJ; Ratcliffe PJ
Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
[TBL] [Abstract][Full Text] [Related]
12. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
Shi M; Guo XT; Shu MG; Chen FL; Li LW
Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
[TBL] [Abstract][Full Text] [Related]
13. Glucose up-regulates HIF-1 alpha expression in primary cortical neurons in response to hypoxia through maintaining cellular redox status.
Guo S; Bragina O; Xu Y; Cao Z; Chen H; Zhou B; Morgan M; Lin Y; Jiang BH; Liu KJ; Shi H
J Neurochem; 2008 Jun; 105(5):1849-60. PubMed ID: 18266932
[TBL] [Abstract][Full Text] [Related]
14. The hypoxic inducible stress response as a target for cancer drug discovery.
Welsh SJ; Koh MY; Powis G
Semin Oncol; 2006 Aug; 33(4):486-97. PubMed ID: 16890803
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting hypoxia-inducible factor 1 for cancer therapy.
Melillo G
Mol Cancer Res; 2006 Sep; 4(9):601-5. PubMed ID: 16940159
[TBL] [Abstract][Full Text] [Related]
16. Harnessing the hypoxia-inducible factor in cancer and ischemic disease.
Brahimi-Horn MC; Pouysségur J
Biochem Pharmacol; 2007 Feb; 73(3):450-7. PubMed ID: 17101119
[TBL] [Abstract][Full Text] [Related]
17. Strongylophorines: natural product inhibitors of hypoxia-inducible factor-1 transcriptional pathway.
Mohammed KA; Jadulco RC; Bugni TS; Harper MK; Sturdy M; Ireland CM
J Med Chem; 2008 Mar; 51(5):1402-5. PubMed ID: 18278856
[TBL] [Abstract][Full Text] [Related]
18. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
[TBL] [Abstract][Full Text] [Related]
19. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
[TBL] [Abstract][Full Text] [Related]
20. Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors.
Görlach A; Kietzmann T
Methods Enzymol; 2007; 435():421-46. PubMed ID: 17998067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
